Singular Genomics Systems Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	30	34	144	833	-	-
Market Cap Growth	-	-76.47%	-82.77%	-	-	-
Enterprise Value	-69	-65	-44	503	-18	-44
PE Ratio	-0.36	-0.36	-1.58	-8.43	-	-
PS Ratio	10.43	11.60	187.59	-	-	-
PB Ratio	0.17	0.19	0.55	2.48	-	-
P/FCF Ratio	-0.45	-0.45	-1.54	-14.73	-	-
P/OCF Ratio	-0.46	-0.46	-1.65	-16.11	-	-
EV/Sales Ratio	-22.50	-22.50	-57.43	-	-	-
EV/EBITDA Ratio	0.76	0.76	0.52	-5.20	0.68	3.66
EV/EBIT Ratio	0.70	0.70	0.49	-5.14	0.66	3.56
EV/FCF Ratio	0.88	0.88	0.47	-8.89	0.69	3.59
Debt / Equity Ratio	0.42	0.42	0.23	0.03	-0.18	-0.10
Debt / EBITDA Ratio	-0.87	-0.87	-0.70	-0.10	-0.35	-0.20
Debt / FCF Ratio	-1.01	-1.01	-0.63	-0.18	-0.36	-0.20
Quick Ratio	9.58	9.58	17.51	50.40	7.43	41.56
Current Ratio	10.51	10.51	19.01	51.57	7.47	41.78
Asset Turnover	0.01	0.01	0.00	0	0	-
Interest Coverage	-85.12	-85.12	-118.11	-115.75	-37.92	-723.94
Return on Equity (ROE)	-45.30%	-45.30%	-31.50%	-40.30%	73.30%	-
Return on Assets (ROA)	-33.30%	-33.30%	-26.30%	-31.20%	-71.00%	-
Return on Capital (ROIC)	-40.43%	-40.43%	-29.29%	-17.71%	65.31%	57.20%
Earnings Yield	-312.16%	-280.83%	-63.33%	-11.86%	-	-
FCF Yield	-245.65%	-220.99%	-64.89%	-6.79%	-	-
Buyback Yield / Dilution	-2.32%	-2.32%	-51.30%	-344.62%	-22.69%	-
Total Shareholder Return	-2.32%	-2.32%	-51.30%	-344.62%	-22.69%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).